EDGAR Filing Documents for 0000950170-24-056262

Form 424B3 - Prospectus [Rule 424(b)(3)]:

SEC Accession No. 0000950170-24-056262

Filing Date

2024-05-09

Accepted

2024-05-09 07:09:02

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B3	lxeo_424b3_q1_2024_10-q.htm	424B3	1622690
2	EX-31.1	lxeo-ex31_1.htm	EX-31.1	11741
3	EX-32.1	lxeo-ex32_1.htm	EX-32.1	6679
4	GRAPHIC	img212167012_0.jpg	GRAPHIC	5674
	Complete submission text file	0000950170-24-056262.txt		1650101

Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010

Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879

Lexeo Therapeutics, Inc. (Filer) CIK: 0001907108 (see all company filings)

IRS No.: 854012572 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-278566 | Film No.: 24928522
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)